View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

EQS-News: Symrise erhöht Dividende und bekräftigt Ausblick

EQS-News: Symrise AG / Schlagwort(e): Jahresergebnis Symrise erhöht Dividende und bekräftigt Ausblick 27.03.2025 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Pressemitteilung — Holzminden, 27. März 2025                       Symrise erhöht Dividende und bekräftigt Ausblick    Dividendenvorschlag von 1,20 € je Aktie (2023: 1,10 €) - 15. Erhöhung in Folge Symrise bekräftigt Jahresziele 2025: Organisches Wachstum von 5-7 % Die Profitabilität (EBITDA-Marge) soll um die 21 % betragen Vertrag von Dr. Stephanie Coßmann...

 PRESS RELEASE

EQS-News: Symrise raises dividend and confirms outlook

EQS-News: Symrise AG / Key word(s): Annual Results Symrise raises dividend and confirms outlook 27.03.2025 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. Press Release — Holzminden, March 27, 2025                       Symrise raises dividend and confirms outlook   Dividend proposal of € 1.20 per share (2023: € 1.10) – 15th increase in succession Symrise confirms targets for 2025: Organic growth of 5-7 % Profitability (EBITDA margin) of around 21 % expected Executive Board contract of Dr. Stephanie Cossmann extended ah...

 PRESS RELEASE

EQS-News: Symrise accelerates in Human Health and Pet Nutrition throug...

EQS-News: Symrise AG / Key word(s): Agreement Symrise accelerates in Human Health and Pet Nutrition through a strategic partnership with HBC 21.02.2025 / 10:15 CET/CEST The issuer is solely responsible for the content of this announcement. Press Release — Holzminden, 21 February 2025 Symrise accelerates in Human Health and Pet Nutrition through a strategic partnership with HBC This partnership ideally complements Symrise’s current portfolio with clinically proven marine ingredients HBC, a leading manufacturer of human grade, sustainable marine proteins, collagens and oi...

Symrise AG: 1 director

A director at Symrise AG bought 210 shares at 95.780EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showi...

Michael B. Schäfer
  • Michael B. Schäfer
 PRESS RELEASE

EQS-News: Symrise erzielt 2024 deutliches Umsatzplus bei stark gestieg...

EQS-News: Symrise AG / Schlagwort(e): Vorläufiges Ergebnis Symrise erzielt 2024 deutliches Umsatzplus bei stark gestiegener Profitabilität (News mit Zusatzmaterial) 30.01.2025 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Pressemitteilung — Holzminden, 30. Januar 2025 Vorläufige Finanzergebnisse 2024                              Organisches Wachstum von 8,7 % / Konzernumsatz steigt um 5,7 % auf rund 5 Mrd. € (2023: 4.7 Mrd. €)                                                                                               ...

 PRESS RELEASE

EQS-News: Symrise achieves significant sales growth in 2024 with a str...

EQS-News: Symrise AG / Key word(s): Preliminary Results Symrise achieves significant sales growth in 2024 with a strong increase in profitability (news with additional features) 30.01.2025 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement.  Press release — Holzminden, January 30, 2025 Preliminary financial results 2024              Organic growth of 8.7% / Group sales increase by 5.7% to around €5 billion (2023: €4.7 billion)  EBITDA of €1,033 million significantly above previous year's figure (2023: €903 million1) EBITDA margin...

Baptiste Salaville ... (+4)
  • Baptiste Salaville
  • Bruno Cavalier
  • Charlotte Vaisse
  • Jerôme Bodin
Baptiste Salaville ... (+3)
  • Baptiste Salaville
  • Bruno Cavalier
  • Jerôme Bodin
CON CONTINENTAL AKTIENGESELLSCHAFT
FME FRESENIUS MEDICAL CARE AG
LHA DEUTSCHE LUFTHANSA AKTIENGESELLSCHAFT
BMW BAYERISCHE MOTOREN WERKE AKTIENGESELLSCHAFT
1COV COVESTRO AG
FRA FRAPORT AG
TKA THYSSENKRUPP AG
WCH WACKER CHEMIE AG
ADS ADIDAS AG
G1A GEA GROUP AG
SLB.N SCHLUMBERGER NV
MC LVMH MOET HENNESSY LOUIS VUITTON SE
ROG ROCHE HOLDING LTD
MTX MTU AERO ENGINES AG
CBK COMMERZBANK AG
HO THALES SA
NOVN NOVARTIS AG
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
DAI DAIMLER AG
GBF BILFINGER SE
RHM RHEINMETALL AG
LXS LANXESS AG
GXI GERRESHEIMER AG
EL ESSILORLUXOTTICA SA
KCO KLOECKNER & CO SE
PSM PROSIEBENSAT.1 MEDIA SE
BRBY BURBERRY GROUP PLC
MRK MERCK KGAA
KER KERING SA
BOSS HUGO BOSS AG
SDF K+S AG
NOEJ NORMA GROUP SE
BAS BASF SE
SAN SANOFI
BAYN BAYER AG
VOW3 VOLKSWAGEN AG PREF
HEN3 HENKEL AG & CO. KGAA PREF
DTE DEUTSCHE TELEKOM AG
SY1 SYMRISE AG
01913 PRADA S.P.A.
DEZ DEUTZ AG
AIXA AIXTRON SE
KRN KRONES AG
NEM NEMETSCHEK SE
SAX STROEER SE & CO. KGAA
EVK EVONIK INDUSTRIES AG
KGX KION GROUP AG
MONC MONCLER SPA
BNR BRENNTAG SE
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
JUN3 JUNGHEINRICH AG PREF
AZN ASTRAZENECA PLC
DUE DURR AG
JST JOST WERKE AG
SHL SIEMENS HEALTHINEERS AG
S92 SMA SOLAR TECHNOLOGY AG
JEN JENOPTIK AG
KBX KNORR-BREMSE AG
HAG HENSOLDT AG
STLA STELLANTIS N.V.
FPE3 FUCHS PETROLUB SE
DTG DAIMLER TRUCK
GSK GSK PLC
STM STABILUS SE
TUI TUI AG
NOVO B NOVO NORDISK A/S
SCHOTT PHARMA AG
R3NK RENK GROUP AG
AGN AEGON N.V.
QGEN QIAGEN N.V.
CVC CVC CAPITAL PARTNERS PLC
SHA SCHAEFFLER AG
Baptiste Salaville ... (+3)
  • Baptiste Salaville
  • Bruno Cavalier
  • Jerôme Bodin
CON CONTINENTAL AKTIENGESELLSCHAFT
FME FRESENIUS MEDICAL CARE AG
LHA DEUTSCHE LUFTHANSA AKTIENGESELLSCHAFT
BMW BAYERISCHE MOTOREN WERKE AKTIENGESELLSCHAFT
1COV COVESTRO AG
FRA FRAPORT AG
TKA THYSSENKRUPP AG
WCH WACKER CHEMIE AG
ADS ADIDAS AG
G1A GEA GROUP AG
SLB.N SCHLUMBERGER NV
MC LVMH MOET HENNESSY LOUIS VUITTON SE
ROG ROCHE HOLDING LTD
MTX MTU AERO ENGINES AG
CBK COMMERZBANK AG
HO THALES SA
NOVN NOVARTIS AG
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
DAI DAIMLER AG
GBF BILFINGER SE
RHM RHEINMETALL AG
LXS LANXESS AG
GXI GERRESHEIMER AG
EL ESSILORLUXOTTICA SA
KCO KLOECKNER & CO SE
PSM PROSIEBENSAT.1 MEDIA SE
BRBY BURBERRY GROUP PLC
MRK MERCK KGAA
KER KERING SA
BOSS HUGO BOSS AG
SDF K+S AG
NOEJ NORMA GROUP SE
BAS BASF SE
SAN SANOFI
BAYN BAYER AG
VOW3 VOLKSWAGEN AG PREF
HEN3 HENKEL AG & CO. KGAA PREF
DTE DEUTSCHE TELEKOM AG
SY1 SYMRISE AG
01913 PRADA S.P.A.
DEZ DEUTZ AG
AIXA AIXTRON SE
KRN KRONES AG
NEM NEMETSCHEK SE
SAX STROEER SE & CO. KGAA
EVK EVONIK INDUSTRIES AG
KGX KION GROUP AG
MONC MONCLER SPA
BNR BRENNTAG SE
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
JUN3 JUNGHEINRICH AG PREF
AZN ASTRAZENECA PLC
DUE DURR AG
JST JOST WERKE AG
SHL SIEMENS HEALTHINEERS AG
S92 SMA SOLAR TECHNOLOGY AG
JEN JENOPTIK AG
KBX KNORR-BREMSE AG
HAG HENSOLDT AG
STLA STELLANTIS N.V.
FPE3 FUCHS PETROLUB SE
DTG DAIMLER TRUCK
GSK GSK PLC
STM STABILUS SE
TUI TUI AG
NOVO B NOVO NORDISK A/S
SCHOTT PHARMA AG
R3NK RENK GROUP AG
AGN AEGON N.V.
QGEN QIAGEN N.V.
CVC CVC CAPITAL PARTNERS PLC
SHA SCHAEFFLER AG
Baptiste Salaville ... (+3)
  • Baptiste Salaville
  • Charlotte Vaisse
  • Jerôme Bodin
Sinan Doganli
  • Sinan Doganli

ODDO : German Investment Seminar in NYC – Feedback from first day of m...

We are hosting our 27th German Investment Seminar in New York from 13 to 15 January 2025. In total, 66 companies are participating. Below, we provide some of our initial feedback on the companies, which were present on day one. Among these companies which were presented during the first day, we notably highlight a positive feedback on BASF, Fresenius Medical Care and Merck AG. We also keep our positive ratings on stocks like Commerzbank, Deutsche Telekom and Schaeffler. We maintain our underperf...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch